Last year, Medicare officials proposed increasing reimbursement rates for some expensive cancer drugs for patients whose bodies don’t respond to […]
Part D Prices for Cancer Drugs Continue to Rise
Despite Medicare Part D closing the infamous donut hole, the prices of some drugs are still on the rise, and […]